TRIM27 and hepatocellular carcinoma: For example, TRIM27 was highly expressed in hepatocellular carcinoma, non-small-cell lung cancer (NSCLC), ovarian cancer and breast cancer (Ma et al., 2016; Liu et al., 2020; Xing et al., 2020; Sakamoto et al., 2022) (Figure 2; Table 1).